三个皮匠报告—— 严选型全行业研究报告分享下载平台，您的专属行业智库！
欢迎来到三个皮匠报告！
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置：
首页
>
行业数据
>
EVER001与利妥昔单抗试验数据对比
EVER001与利妥昔单抗试验数据对比
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式：PNG
图片大小：171KB
图片尺寸：1808*843
同报告图片
/
4
fCDmlbDmja7mnaXmupAgfCAyNOWRqElDUiAoJSkgfCAyNOWRqDI05bCP5pe26JuL55m9Q1IrUFIgKCUpIHwKfCAtLS0gfCAtLS0gfCAtLS0gfAp8IEVWRVIwMDEg6Zif5YiXMSB8IDc3JSAobj0xMykgfCA0MiUgKG49MTIpIHwKfCBFVkVSMDAxIOmYn+WIlzIgfCAxMDAlIChuPTcpIHwgODYlIChuPTcpIHwKfCBSVFggKyBOSUFUIHwgNTAlIHwgMzUlIHwKfCBOSUFUIHwgMTIlIHwgMjElIHwKfCBSVFggfCA1MiUgfCAzNSUgfAp8IENzQSB8IDI4LjMlIHwgNDkuMCUgfAp8IFJUWCB8IDYzJSB8IDUxJSB8CnwgTVArQ1lDIHwgNTAlIHwgNjElIHwKCui1hOaWmeadpea6kO+8muS6kemhtuaWsOiAgOWumOe9ke+8jOmVv+WfjuivgeWIuOS6p+S4mumHkeiejeeglOeptumZouOAgg==
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
所属报告：
膜性肾病专题：200万人以上大病种未被满足需求庞大-241210（33页）.pdf
打包全文图表
相关数据
度普利尤单抗（达必妥）全球销售额（2017-2025年）
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
收藏
行业数据
2026-05-28
原图定位
查看详情
汉利康（利妥昔单抗生物类似药）License-out合作梳理
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
收藏
行业数据
2025-06-30
原图定位
查看详情
利妥昔单抗国内样本医院销售额（2013-1H24）
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
收藏
行业数据
2025-06-30
原图定位
查看详情
利妥昔单抗广东集采前后价格（元）及降幅（%）
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
收藏
行业数据
2025-04-28
原图定位
查看详情
图表43我国西妥昔单抗市场规模/亿元
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
收藏
市场规模
2025-04-25
原图定位
查看详情
西妥昔单抗样本医院销售额（万人民币）
fCDlubTku70gfCDlhaznq4vljLvpmaLnu4jnq68gfCDpm7bllK7oja/lupfnu4jnq68gfCDlhaznq4vln7rlsYLljLvnlpfnu4jnq68gfCDlkIjorqHplIDllK7pop3lop7plb/njocgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS18LS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS18CnwgMjAyMOW5tCB8IDE1MCwwMDDkuIflhYMgfCAxMCwwMDDkuIflhYMgfCA1LDAwMOS4h+WFgyB8IDExLjY4JSB8CnwgMjAyMeW5tCB8IDE4MCwwMDDkuIflhYMgfCAxNSwwMDDkuIflhYMgfCAxMCwwMDDkuIflhYMgfCAyMS4zNSUgfAp8IDIwMjLlubQgfCAyMDAsMDAw5LiH5YWDIHwgMjAsMDAw5LiH5YWDIHwgMTUsMDAw5LiH5YWDIHwgMjUlIHwKCui1hOaWmeadpea6kO+8muWMu+iNr+e7j+a1juaKpeWFrOS8l+WPt++8jOS4reazsOivgeWIuOeglOeptuaJgA==
收藏
行业数据
2025-02-25
原图定位
查看详情
维布妥昔单抗中国销售额（百万元）和增长率
fCDlubTku70gfCDplIDllK7pop3vvIjnmb7kuIflhYPvvIkgfCDlop7plb/njocgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS18LS0tLS0tLS18CnwgMjAyMCB8IDE4ICAgICAgICAgICAgIHwgLSAgICAgIHwKfCAyMDIxIHwgNjEgICAgICAgICAgICAgfCAyNDYuNiUgfAp8IDIwMjIgfCAxMzMgICAgICAgICAgICB8IDExOS4wJSB8CnwgMjAyMyB8IDI0OCAgICAgICAgICAgIHwgODYuNSUgIHwKCui1hOaWmeadpea6kO+8muS4reW6t+W8gOaAne+8jOS4nOWQtOivgeWIuOeglOeptuaJgA==
收藏
行业数据
2025-02-06
原图定位
查看详情
利妥昔单抗实际降幅平均值相对温和，依那西普因上市时间早竞争格局相对充分，集采降幅整体较大
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
收藏
竞争格局
2025-02-06
原图定位
查看详情
EVER001与利妥昔单抗试验数据对比
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
收藏
行业数据
2024-12-25
原图定位
查看详情
阿布昔替尼的应答率及应答时间优于度普利尤单抗
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
收藏
行业数据
2024-12-12
原图定位
查看详情
中国已获批及处于研发阶段的西妥昔单抗仿制药
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
收藏
行业数据
2024-11-29
原图定位
查看详情
利妥昔单抗国内竞争格局（NDA及以上）
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
收藏
竞争格局
2024-10-21
原图定位
查看详情
西妥昔单抗国内市场潜力较大（亿元）
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
收藏
行业数据
2024-08-14
原图定位
查看详情
2021年西妥昔单抗全球销售超17亿美元
fCDlubTku70gfCDpu5jlhYvliLboja8gfCDnpLzmnaXliLboja8gfAp8LS0tLS0tfC0tLS0tLS0tLS18LS0tLS0tLS0tLXwKfCAyMDE2IHwgMTAgICAgICAgfCA2ICAgICAgICB8CnwgMjAxNyB8IDEwICAgICAgIHwgNiAgICAgICAgfAp8IDIwMTggfCAxMCAgICAgICB8IDYgICAgICAgIHwKfCAyMDE5IHwgMTAgICAgICAgfCA1ICAgICAgICB8CnwgMjAyMCB8IDEwICAgICAgIHwgNSAgICAgICAgfAp8IDIwMjEgfCAxMCAgICAgICB8IDcgICAgICAgIHwKfCAyMDIyIHwgMTAgICAgICAgfCAwICAgICAgICB8CnwgMjAyMyB8IDEwICAgICAgIHwgMCAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77yaSW5zaWdodOOAgeW8gOa6kOivgeWIuOeglOeptuaJgA==
收藏
行业数据
2024-08-14
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模（亿美元）
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模（亿美元）
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模（百万美元）
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
EVER001 较抗 CD20 单抗等免疫抑制药物均体现出疗效优势。2020 年发表的一项评估贝利尤单抗对抗 PLA2R 阳性原发性膜性肾病患者（n=11）的作用。结果显示，8 例患者达到部分缓解，1 例患者达到完全缓解，且该药对降低抗 PLA2R 抗体有明显效果。2024年发表的菲泽妥单抗临床 1b/2a 期试验结果显示，18 例初诊或复发的原发性膜性肾病患者（Cohort 1）和 13 例其他免疫抑制剂治疗无效的患者（Cohort 2）在 52 周治疗观察期内，免疫缓解率合计为 76.9%；部分缓解率分别为 46.7%、18.2%。2024 年发表的泽布替尼临床 2/3 期 Part I 的单臂实验结果显示，24 周时 20 例患者中有 6 例实现部分缓解，12 例实现免疫缓解。2024 年发表的 EVER001 临床 1b/2a期的部分实验结果显示，24 周时 200mg 组总体缓解率 85.7%、免疫缓解率 100%；36 周时 100mg 组总体缓解率 81.8%、免疫缓解率 90.9%。
行业数据
原图定位
当前图表所属：
膜性肾病专题：200万人以上大病种未被满足需求庞大-241210（33页）.pdf
2025年膜性肾病行业报告：患者270万，利妥昔单抗耐药困境
主要原发性肾小球疾病病患数占肾活检总样本的比例及变化
肾小球疾病病因构成
原发性肾小球疾病分类
下载图片或Excel，需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利，扫码领取！
关注公众号『三个皮匠报告』，免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码？
验证即登录，未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》
研搜
0731-84720580
商务合作：really158d
下载Excel
下载图片
原图定位
打包全文图表
收藏
2026-05-28
原图定位
微信扫码登录
手机快捷登录
账号登录
